About Terray Therapeutics
Terray Therapeutics focuses on discovering and developing small molecule drugs using a combination of experimental techniques and computational methods. The company collects and analyzes a large amount of data, with over two billion unique target-ligand binding measurements, to enhance the drug discovery process. By employing deep learning regression models, Terray can predict molecular properties accurately. Their efficient design-make-test-analyze cycle allows them to test millions of molecules quickly, identifying effective treatments for various diseases, particularly in immunology. Unlike many competitors, Terray integrates both wet lab science and AI in their workflow, and they also collaborate with large pharmaceutical and biotech companies to tackle a wide range of therapeutic challenges. The goal of Terray Therapeutics is to provide effective small molecule drugs that can address significant health issues.